TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | -1 | 0 | 5 | -0 | 18 | 76 | 16 |
| S | %wins | 80 | 40 | 20 | 60 | 40 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/24 19:54 | 2/2/24 | ABUS | Arbutus Biopharma Corp | A1 | Health | Drug | Pharmaceutical Preparations | Hastings David C | PA | O | CFO | S.d | -22 | 2.31 | 0 | -10 | -5 | 182 | D | ||||||||||||||
6/6/14 18:47 | 6/4/14 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | S.dm | -10,547 | 52.73 | 33 | -200 | -96 | 9 | D | 158 | 158 | 16 | -19 | 12 | 4 | 8 | 8 | 3 | 2 | 3 | 0 | 42 | 107 |
2/18/14 18:03 | 2/13/14 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | S.dm | -18,112 | 65.86 | 33 | -275 | -97 | 9 | D | 250 | 212 | 141 | 46 | 23 | 3 | 3 | -3 | -6 | 2 | -1 | -25 | -22 | 19 |
9/9/13 16:13 | 9/6/13 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | S.d | -3,516 | 35.16 | 33 | -100 | -92 | 9 | D | 143 | 78 | 51 | 66 | 53 | 34 | 4 | 4 | -2 | -3 | 2 | 25 | 72 | 42 |
2/20/13 16:33 | 2/15/13 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | S.d | -2,252 | 22.52 | 33 | -100 | -92 | 9 | D | 50 | 27 | 18 | 34 | 22 | 18 | 21 | 17 | -1 | -1 | 8 | 9 | 24 | 185 |
6/10/11 17:06 | 6/9/11 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | S.d | -1,774 | 17.74 | 33 | -100 | -92 | 9 | D | 444 | 43 | 15 | 35 | -3 | -4 | 2 | 7 | -1 | 1 | 11 | -11 | -24 | 29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |